FDA Chides Mylan Over Puerto Rico Plant Violations
The U.S. Food and Drug Administration found several violations of manufacturing regulations at a Mylan Inc. facility in Puerto Rico, including a failure to test drugs for uniformity, according to a...To view the full article, register now.
Already a subscriber? Click here to view full article